Boggy Uterus · What Is It, Causes, Treatment, and More

Boggy uterus refers to a clinical finding in which the uterus is identified as enlarged and soft.  

The uterus, a muscular organ of the reproductive system, is capable of stretching to accommodate a growing fetus. The wall of the uterus consists of three layers: the perimetrium (outer), myometrium (middle), and endometrium (inner).  

Uterine atony and adenomyosis are the most common causes of a boggy uterus. Uterine atony refers to the failure of the uterus to contract sufficiently during and after delivery.  Uterine atony can occur when the uterus is unable to respond to oxytocin, a hormone the body releases before and during childbirth to stimulate uterine contractions. As a result, the uterus may lose its normal tone, becoming larger and softer than expected.     

Adenomyosis is a gynecologic condition in which endometrial tissue is present within the myometrium. The underlying cause of adenomyosis is unknown; however, one of the most commonly accepted theories is that the deepest layer of the endometrium invades the myometrium. Adenomyosis leads to angiogenesis, or the increased formation of small blood vessels, and these blood vessels supply the endometrial glands and stroma in the myometrium (i.e., ectopic endometrial tissue). With adenomyosis, there is also an increase in the size and number of the myometrial smooth muscles (i.e., hypertrophy and hyperplasia, respectively). As a result, the uterus increases in size and loses its firm consistency.  

A boggy uterus can also be indicative of several other underlying conditions. Endometritis, often resulting from an infection following delivery, miscarriage, or invasive uterine procedures, leads to inflammation of the uterine lining and a soft, tender uterus. Retained products of conception, commonly occurring after an incomplete miscarriage or abortion, can prevent the uterus from fully contracting, resulting in a boggy texture and potential bleeding. Lastly, choriocarcinoma, a rare but aggressive form of gestational trophoblastic disease, may present as a boggy uterus with irregular bleeding and elevated human chorionic gonadotropin (hCG) levels, necessitating prompt evaluation and treatment. 

A healthy uterus is a muscular organ and presents with resistance upon physical examination. In contrast, a boggy uterus will feel large and soft, lacking the expected resistance. Additionally, a boggy uterus is usually very tender. Therefore, individuals with a boggy uterus may experience pain, mostly in the lower abdomen and back.  

Additional signs and symptoms may differ depending on the underlying condition. Excessive blood loss after childbirth, called postpartum hemorrhage, is the major sign of uterine atony. Excessive blood loss can cause a severe drop in blood pressure and cause a life-threatening emergency.  

Symptoms of adenomyosis typically include heavy bleeding, painful menstruation, and, at times, dyspareunia (i.e., painful intercourse). Rarely, individuals with adenomyosis may be asymptomatic, or without symptoms.  

When diagnosing a boggy uterus, physical examination and review of the individual’s medical history are necessary to identify the underlying cause. Uterine atony is usually diagnosed during physical examination immediately upon vaginal or cesarean delivery. To assess the uterine tone, direct palpation of the uterus is performed after a cesarean section, whereas indirect bimanual examination, involving examination of the abdomen with one hand while performing a vaginal examination with the other hand, is performed after vaginal delivery. 

Often, physical examination is enough to reveal the characteristic enlarged uterus. However, a transabdominal or transvaginal ultrasound may be performed in order to confirm diagnosis, especially when adenomyosis is suspected. A magnetic resonance imaging (MRI) scan may also be performed and reveal similar findings as the ultrasound. Imaging is often optimized when performed when performed in the late proliferative or secretory phase of the menstrual cycle (i.e., days 10 to 28), when myometrial differentiation is more apparent.  

There are three characteristic findings in individuals with adenomyosis. First, ectopic endometrial tissue is identified on ultrasound as echogenic nodules and linear striations emerging from the endometrium to the myometrium. Second, diverse myometrial echotexture (i.e.,the characteristic pattern of tissue layers as seen in an ultrasound) can be identified on ultrasound due to uneven myometrial thickening. Finally, increased vascularity may be observed on Doppler imaging.  

Endometritis is typically diagnosed through clinical signs of infection, including fever, uterine tenderness, and discharge, supported by elevated inflammatory markers like c-reactive protein (CRP) or white blood cell count.  

Transvaginal ultrasound plays a pivotal role in identifying retained products of conception, revealing echogenic material or a thickened endometrial stripe within the uterine cavity. 

Choriocarcinoma is diagnosed based on markedly elevated serum hCG levels disproportionate to pregnancy status, along with imaging findings of uterine masses, and is confirmed by histopathologic analysis.

Treatment options for a boggy uterus vary depending on the underlying cause. Uterine atony is considered a medical emergency requiring immediate intervention. The administration of medications, such as oxytocin, prostaglandins, and uterotonic agents, can help restore the tone of the uterus and induce uterine contractions. In the case of excessive postpartum hemorrhage, uterine massage in combination with tamponade, which applies pressure to the uterine walls, may be performed. Uterine artery ligation, which involves applying stitches to the main artery that supplies blood to the uterus, and other surgical techniques may be needed to stop the bleeding (e.g., B-Lynch suturing). When the bleeding is unmanageable, a hysterectomy, or surgical removal of the uterus, may be necessary to save the individual’s life.  

Treatment for adenomyosis largely depends on symptom severity and the individual’s reproductive goals. Medical management focuses on symptoms associated with this condition. For example, non-steroidal anti-inflammatory drugs (NSAIDs) may provide some relief for heavy periods with painful cramping. Various hormonal therapies, including oral contraceptive pills (OCPs) and hormonal intrauterine devices (IUD), are also available. These therapies reduce the effects of estrogen on the endometrium, preventing the rapid growth of the endometrial tissue, including the ectopic endometrial tissue present in the myometrium.  

When medication cannot sufficiently manage symptoms of adenomyosis, minimally invasive and surgical therapies are suggested. For example, one available treatment option is MRI-guided or ultrasound-guided thermal ablation (i.e., removal) of sites of adenomyosis. Uterine artery embolization, a procedure during which the overall blood flow to the uterus is reduced to decrease the size of the uterus, can also be helpful in individuals with adenomyosis. A partial hysterectomy is a more invasive treatment option. While this procedure may preserve fertility, scarring between the endometrial and myometrial layers is a potential complication. Total hysterectomy is the most definitive treatment for adenomyosis, although complete surgical removal of the uterus is typically suggested only when all other options have been exhausted. 

Endometritis is managed with broad-spectrum antibiotics with hospitalization for intravenous (IV) therapy in severe cases. Retained products of conception are treated with uterine evacuation via suction curettage or medications like misoprostol to promote evacuation of the uterine cavity.  

For choriocarcinoma, management involves systemic chemotherapy tailored to the risk stratification of the disease, with methotrexate being commonly used in low-risk cases and multi-agent regimens like EMA-CO for high-risk disease. Early intervention ensures optimal outcomes.